ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/14 | 2,053 | 2,081 | 2,036 | 2,078 | +57 | +2.8% | 99,100 |
| 2024/06/13 | 2,030 | 2,030 | 2,010 | 2,021 | -4 | -0.2% | 33,100 |
| 2024/06/12 | 2,024 | 2,035 | 2,011 | 2,025 | -4 | -0.2% | 26,500 |
| 2024/06/11 | 2,042 | 2,053 | 2,029 | 2,029 | -17 | -0.8% | 41,400 |
| 2024/06/10 | 2,042 | 2,050 | 2,038 | 2,046 | +4 | +0.2% | 28,400 |
| 2024/06/07 | 2,038 | 2,044 | 2,024 | 2,042 | +4 | +0.2% | 60,600 |
| 2024/06/06 | 2,044 | 2,044 | 2,019 | 2,038 | -6 | -0.3% | 48,200 |
| 2024/06/05 | 2,037 | 2,052 | 2,029 | 2,044 | +7 | +0.3% | 61,400 |
| 2024/06/04 | 2,005 | 2,052 | 1,996 | 2,037 | +37 | +1.9% | 82,500 |
| 2024/06/03 | 1,989 | 2,007 | 1,989 | 2,000 | +13 | +0.7% | 39,200 |
| 2024/05/31 | 1,960 | 1,987 | 1,960 | 1,987 | +38 | +1.9% | 72,400 |
| 2024/05/30 | 1,936 | 1,949 | 1,921 | 1,949 | +10 | +0.5% | 50,500 |
| 2024/05/29 | 1,960 | 1,966 | 1,935 | 1,939 | -22 | -1.1% | 45,000 |
| 2024/05/28 | 1,969 | 1,969 | 1,957 | 1,961 | +1 | +0.1% | 24,900 |
| 2024/05/27 | 1,959 | 1,965 | 1,947 | 1,960 | +7 | +0.4% | 40,100 |
| 2024/05/24 | 1,940 | 1,958 | 1,938 | 1,953 | +3 | +0.2% | 38,700 |
| 2024/05/23 | 1,957 | 1,968 | 1,944 | 1,950 | -9 | -0.5% | 74,600 |
| 2024/05/22 | 1,989 | 1,989 | 1,957 | 1,959 | -21 | -1.1% | 52,900 |
| 2024/05/21 | 2,010 | 2,010 | 1,980 | 1,980 | -21 | -1% | 70,700 |
| 2024/05/20 | 2,009 | 2,017 | 2,001 | 2,001 | -8 | -0.4% | 36,400 |
| 2024/05/17 | 1,995 | 2,013 | 1,991 | 2,009 | +9 | +0.5% | 42,900 |
| 2024/05/16 | 2,032 | 2,035 | 1,990 | 2,000 | -25 | -1.2% | 70,000 |
| 2024/05/15 | 2,065 | 2,067 | 2,025 | 2,025 | -20 | -1% | 44,600 |
| 2024/05/14 | 2,039 | 2,068 | 2,030 | 2,045 | +6 | +0.3% | 61,400 |
| 2024/05/13 | 2,017 | 2,042 | 2,009 | 2,039 | +38 | +1.9% | 87,800 |
| 2024/05/10 | 2,059 | 2,071 | 1,996 | 2,001 | -108 | -5.1% | 226,400 |
| 2024/05/09 | 2,115 | 2,116 | 2,091 | 2,109 | +10 | +0.5% | 68,500 |
| 2024/05/08 | 2,105 | 2,107 | 2,090 | 2,099 | +4 | +0.2% | 48,000 |
| 2024/05/07 | 2,111 | 2,111 | 2,085 | 2,095 | -24 | -1.1% | 43,300 |
| 2024/05/02 | 2,102 | 2,130 | 2,098 | 2,119 | +21 | +1% | 58,300 |
| 2024/05/01 | 2,082 | 2,106 | 2,075 | 2,098 | +5 | +0.2% | 34,400 |
| 2024/04/30 | 2,076 | 2,099 | 2,056 | 2,093 | +34 | +1.7% | 52,100 |
| 2024/04/26 | 2,063 | 2,064 | 2,033 | 2,059 | +11 | +0.5% | 31,400 |
| 2024/04/25 | 2,067 | 2,072 | 2,044 | 2,048 | -15 | -0.7% | 43,500 |
| 2024/04/24 | 2,058 | 2,072 | 2,056 | 2,063 | +6 | +0.3% | 26,900 |
| 2024/04/23 | 2,056 | 2,065 | 2,047 | 2,057 | -1 | ±0% | 17,900 |
| 2024/04/22 | 2,035 | 2,061 | 2,035 | 2,058 | +45 | +2.2% | 32,800 |
| 2024/04/19 | 2,039 | 2,039 | 1,996 | 2,013 | -28 | -1.4% | 49,900 |
| 2024/04/18 | 2,025 | 2,052 | 2,023 | 2,041 | +16 | +0.8% | 38,400 |
| 2024/04/17 | 2,060 | 2,060 | 2,025 | 2,025 | -38 | -1.8% | 50,900 |
| 2024/04/16 | 2,080 | 2,082 | 2,058 | 2,063 | -25 | -1.2% | 47,700 |
| 2024/04/15 | 2,090 | 2,090 | 2,076 | 2,088 | -4 | -0.2% | 31,400 |
| 2024/04/12 | 2,085 | 2,100 | 2,079 | 2,092 | +7 | +0.3% | 37,900 |
| 2024/04/11 | 2,078 | 2,093 | 2,071 | 2,085 | -13 | -0.6% | 35,000 |
| 2024/04/10 | 2,104 | 2,110 | 2,096 | 2,098 | +3 | +0.1% | 30,500 |
| 2024/04/09 | 2,105 | 2,105 | 2,085 | 2,095 | ±0 | ±0% | 38,900 |
| 2024/04/08 | 2,087 | 2,101 | 2,075 | 2,095 | +26 | +1.3% | 50,500 |
| 2024/04/05 | 2,048 | 2,069 | 2,038 | 2,069 | +10 | +0.5% | 39,900 |
| 2024/04/04 | 2,070 | 2,071 | 2,055 | 2,059 | -16 | -0.8% | 57,500 |
| 2024/04/03 | 2,075 | 2,084 | 2,056 | 2,075 | -11 | -0.5% | 47,500 |
1～
50
件表示中 / 3477件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 207,800円 | +9.6% | +17.5% | 2.21% | 11.74倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 住友ファーマ | 34,200円 | +7.5% | - | 0.00% | - | 0.87倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ジーエヌアイ | 229,000円 | +52.1% | +23.3% | 0.00% | 16.21倍 | 3.39倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 持田薬 | 292,200円 | +3.0% | +27.5% | 2.74% | 18.50倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 168,300円 | +3.2% | +4.5% | 3.09% | 19.34倍 | 0.74倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
